Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


6 Items
Title  Creator  Group name  Publishing year 
[The morbidity and mortality review meetings in radiotherapy departments: Procedure, implementation and prospects of the "Proust" French national project] Belkacemi et al. EquipeJPP 2023-09
The role of radiation therapy for de novo metastatic bladder and renal cancers Sargos et al. EquipeJPP 2023-06-05
Specificities of clinical research in radiotherapy Hennequin et al. EquipeJPP 2022
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers] Latorzeff et al. EquipeAP Feb 11, 2020
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group Belkacemi et al. EquipeJPP 2020-12
[Stereotactic body radiation therapy and oligometastases] Bourgier et al. EquipeNB 2014 Jul-Aug
6 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés